NovoCure Ltd. (NVCR) PT Raised to $44 at Mizuho Securities

July 27, 2018 8:44 AM

Mizuho Securities raised its price target on NovoCure Ltd. (NASDAQ: NVCR) to $44.00 (from $32.00) while maintaining a Buy rating.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found